From: Management strategy and outcomes of sacrococcygeal teratoma — an Egyptian multicenter experience
Study and year | Number of patients | Abdominoperineal approach (n) | Perineal incision: commonest (n) | Intraoperative complications (n) | Pathology (n) | Relapse (n) | Mortality (n) | Overall survival | Bowel dysfunction (n) | Bladder dysfunction (n) | |
---|---|---|---|---|---|---|---|---|---|---|---|
Benign/immature | Malignant | ||||||||||
Current study (2023) | 95 | 20 | Vertical; 49 | 7 | 88 | 7 | 8 | 5 | 94% | 12 | 7 |
Braungart (2023) [22] | 165 | - | - | 8 | 151 | 14 | 13 | 5 | 97% | 52 | 22 |
O'Shea (2022) [30] | 32 | 6 | Vertical; 24 | - | 26 | 6 | 0 | 0 | 100% | 1 | 4 |
Masahata (2020) [23] | 29 | 7 | Chevron; 29 | 3 | 28 | 1 | 0 | 1 | 96.6% | 6 | 4 |
Hambraeus (2019) [35] | 53 | - | - | - | 52 | 1 | 8 | 4 | 95.2% | 19 | 24 |
Padilla (2017) [1] | 40 | - | Chevron; 40 | - | 38 | 2 | 5 | 2 | 95% | - | - |
Hambraeus (2016) [31] | 19 | - | - | 4 | - | - | 0 | 2 | 89% | - | - |
Hassan (2014) [16] | 20 | 3 | Chevron; 17 | 2 | 19 | 1 | 2 | 1 | 95% | 9 | 0 |
Jan 2011 [28] | 19 | 0 | Vertical; 19 | 0 | 14 | 5 | 0 | 0 | 100% | 5 | 0 |
Tailor (2009) [36] | 9 | 4 | Chevron; 5 | 4 | 9 | 0 | 1 | 0 | 100% | 1 | 3 |
Gabra (2006) [19] | 33 | 8 | Chevron; 33 | 3 | 27 | 6 | 3 | 2 | 94% | 5 | 4 |